U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07428460) titled 'Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia' on Feb. 12.
Brief Summary: The goal of this clinical trial is to learn if an accelerated form of neuromodulation therapy can help improve negative symptoms of schizophrenia. Negative symptoms can include low motivation, reduced emotional expression, and difficulty with social interaction. The study will also look at how safe and tolerable this treatment is when given over a short period of time.
Participants will be randomly assigned to receive either active neuromodulation therapy or sham (placebo) stimulation. The study will also compare two different way...